Comparison
1p35 2 Microdeletion Syndrome vs 12q15q21 1 Microdeletion Syndrome C4518344
Clinical comparison between 1p35 2 Microdeletion Syndrome and 12q15q21 1 Microdeletion Syndrome for differential diagnosis and treatment planning.
6 comparison axes
Onset
1p35 2 Microdeletion Syndrome
0-null
12q15q21 1 Microdeletion Syndrome C4518344
0-0
Onset patterns differ
Severity
1p35 2 Microdeletion Syndrome
severe
12q15q21 1 Microdeletion Syndrome C4518344
moderate
Different severity levels
Chronic
1p35 2 Microdeletion Syndrome
Chronic
12q15q21 1 Microdeletion Syndrome C4518344
Chronic
Differing course
Communicable
1p35 2 Microdeletion Syndrome
No
12q15q21 1 Microdeletion Syndrome C4518344
No
Different transmission
Body System
1p35 2 Microdeletion Syndrome
congenital
12q15q21 1 Microdeletion Syndrome C4518344
congenital
Same/different system
Category
1p35 2 Microdeletion Syndrome
rare-disease
12q15q21 1 Microdeletion Syndrome C4518344
genetic
Different category
Bottom line
1p35-2-microdeletion-syndrome-C5679992 and 12q15q21-1-microdeletion-syndrome-C4518344 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 1p35 2 Microdeletion Syndrome | 12q15q21 1 Microdeletion Syndrome C4518344 | Discriminating power |
|---|---|---|---|
| Developmental concerns | Specific developmental features are not established in the supplied data. | Source notes variable developmental concerns, without a fixed pattern. | Low |
| Severity label | Axis data list severe, but clinical details are absent. | Axis data list moderate, with variable medical issues. | Moderate |
| Onset information | Onset is coded incompletely as 0-null. | Onset is coded as present from birth, 0-0. | Low |
When to favor each condition
Choose 1p35 2 Microdeletion Syndrome when
Testing shows a deletion involving 1p35.2
The chromosomal locus, not symptoms alone, separates these concepts.
High
Clinical genetics links 1p35.2 to the findings
Pathogenicity and relevance require specialist interpretation.
Moderate
No established feature list is available
Avoid assigning the other syndrome when evidence is incomplete.
High
Choose 12q15q21 1 Microdeletion Syndrome C4518344 when
Testing shows a deletion involving 12q15q21.1
The reported locus matches the right-sided concept.
High
Variable developmental or medical issues are present
This fits the sparse source description but is not diagnostic alone.
Low
Symptom-directed multidisciplinary care is planned
The source supports addressing identified problems rather than a fixed regimen.
Moderate
How key tests differ
| Test | 1p35 2 Microdeletion Syndrome | 12q15q21 1 Microdeletion Syndrome C4518344 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May identify a copy-number loss at 1p35.2. | May identify a copy-number loss at 12q15q21.1. | Locus and gene content require laboratory and clinician review. |
| Karyotype | A small deletion may not be visible. | A small deletion may not be visible. | A normal karyotype does not exclude either microdeletion. |
| Clinical genetics assessment | Correlates the 1p35.2 result with phenotype. | Correlates the 12q result with variable findings. | An abnormal result is distinct from a confirmed clinical diagnosis. |
Prognosis comparison
1p35 2 Microdeletion Syndrome
- Outcome
- Long-term outcome is not established from supplied data.
- Factors
- Reported severe label, incomplete onset data, and lack of phenotype detail.
12q15q21 1 Microdeletion Syndrome C4518344
- Outcome
- Outcome varies; a moderate label does not predict an individual course.
- Factors
- Variable developmental concerns, medical issues, and confirmed deletion content.
Time frame: Both are coded chronic, but no reliable timeline is supplied.
Exact locus, gene content, associated findings, and access to coordinated care.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental complications | Specific complications are not established. Developmental concerns may occur but vary. Do not infer a complication without individual assessment. |
| Associated medical issues | No source list is supplied. Medical issues are described only as variable. Surveillance should follow identified needs, not assumptions. |
| Misclassification | Sparse data increase uncertainty. Variable presentation can overlap other conditions. Genetic confirmation and specialist review reduce mislabeling. |
Patient education highlights
- HighGenetic confirmation
The named syndrome depends on the deleted chromosomal region and specialist interpretation.
- HighVariable presentation
Features and needs can differ; absent source details do not prove absence of problems.
- MediumCare planning
Care is individualized and multidisciplinary; no dose or standard treatment is established here.